Caladrius Biosciences, Inc. - stock earnings
Stock symbol CLBS is outdated, potentially delisted? Maybe it is available on other exchange?
CLBS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q2 | -6.6 million USD | ? USD |
| 2022Q1 | -4.2 million USD | ? USD |
| 2021Q4 | -6.8 million USD | ? USD |
| 2021Q3 | -6.9 million USD | ? USD |
| 2021Q2 | -5.7 million USD | ? USD |
| 2021Q1 | -8.1 million USD | ? USD |
| 2020Q4 | -5.4 million USD | ? USD |
| 2020Q3 | -5.3 million USD | ? USD |
| 2020Q2 | 6.6 million USD | ? USD |
CLBS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -27.5 million USD | ? USD |
| 2020 | -8.2 million USD | ? USD |
| 2019 | -19.4 million USD | ? USD |
| 2018 | -16.2 million USD | ? USD |
| 2017 | 23.0 million USD | ? USD |
CLBS
Price: $0.43
52 week price:
Forward Dividend Yield: 21.38%
Earnings Per Share: -0.36 USD
P/E Ratio: -2.40
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 26.9 million
Ebitda: -5.9 millionMarket Capitalization: 25.8 million